Chicago Atlantic Real Estate Finance, Inc. (REFI) Earnings Call Transcript & Summary
May 12, 2022
Earnings Call Speaker Segments
Harry Sullivan
executiveThanks. Morning, everyone. Pleasure to have you join us for Chicago Atlantic Real Estate Finance's conference call, where we'll go over what the company achieved during 2022's first quarter. Joining us on this call are John Mazarakis, our Executive Chairman; Tony Cappell, Chief Executive Officer; and Andreas Bodmeier, Co-President and Chief Investment Officer. This morning we put out our results through the earnings press release, available in the Investor Relations portion of our site, together with the supplemental we filed with the SEC. A live audio webcast is accessible today. If you happen to be listening to the replay of this webcast, please note that anything said here reflects remarks as of today, May 12, 2022, and no updates will follow after this call. Throughout this call, some of our comments and statements could be forward-looking statements under the meaning set forth by securities laws, such as statements about our portfolio's future performance, our pipeline of potential loans and other investments, future dividends, and financing activities. Every forward-looking statement reflects Chicago Atlantic's judgment as of this conference call's date and carries risks and uncertainties that may lead actual results to differ materially from what we currently expect. We encourage investors to review carefully the various disclosures the company has made, including risk and other information in the company's SEC filings. We'll also cover certain non-GAAP measures, among them distributable earnings and adjusted distributable earnings, though not limited to those. You can find definitions of these non-GAAP measures and reconciliations to the most comparable GAAP measures in our SEC filings. I'll hand things over now to John Mazarakis. Go ahead.
John Mazarakis
executiveThank you, Tripp. Morning, everybody, and I appreciate you being with us today. It's only been a short period since we reported Q4 in mid-March, so before giving a brief recap of what we've done since that last call, I'd like to speak to a few of the macroeconomic topics that everyone is focused on right now. Let's begin with what's top of mind. Yes, the wider market has legitimate worries — rates climbing, the conflict in Ukraine, and the question of whether the Federal Reserve tips the economy into a recession — but in our view, people have completely misplaced their sense of proportion regarding how much upside exists in cannabis lending. I'd also say the market seems to have forgotten why we've held such a bullish stance on this sector over the last 4 years. Nobody can argue that rates aren't going up, or that cannabis operators haven't seen serious turmoil in the equity markets. What people are missing is just how resilient this business is — it's countercyclical and has no correlation to the wider market. Its behavior resembles the pharmaceutical sector, and also alcohol and tobacco; those industries keep showing demand that varies in elasticity, and cannabis behaves very similarly. Cannabis is expanding at roughly 20% annually, and that expansion doesn't hinge on the broader economy. What it's tied to is regulation and the addition of licenses inside states that already permit it. Few industries let you draw a direct line between fresh regulations and fresh licensing, on one side, and the need for capital, on the other. Take New Jersey — a perfect illustration. It used to be a $300 million medical market. With the shift to adult use, it's now comfortably a $1 billion retail market, and whether or not there's a recession, that won't change. That's exactly why we're so busy. Georgia, Ohio, Illinois, Arizona, Maryland and Alabama are among the states adding licenses, and Florida has picked up a new one too. Those states are what's fueling our growth. Roughly 63% of our loans are tied to Prime. None of our loans are LIBOR-based. Because these are floating rate loans, we can move along with the market. You'll see that as of May 10, our weighted average yield to maturity rose to 17.5%. I'd also point out that our portfolio currently holds $337 million in commitments, and as of Monday our market cap was above $290 million. As of March 31 we had taken on no leverage, and since then we've drawn $30 million against our credit facility. On an unlevered basis, we're trading at a yield to book of about 10.6%. That's why I believe we need to restore some perspective about what's happening in our markets and in our business. Our operators are in excellent shape too. Normally they carry no leverage apart from our loans. In a typical setup, operators would hold leverage of 4x to 6x debt-to-EBITDA, and then a mortgage REIT would layer a couple of turns of leverage on top of that; that isn't what you find in our portfolio. A recent addition to our portfolio involves a borrower sitting at $11 million in EBITDA, while the loan we extended comes to just $17 million, and there's no additional debt anywhere in that borrower's capital structure. From the start, my aim has been to keep enhancing the trust people place in us as a provider of capital and to expand alongside the top-tier operators in this space. Our focus is mainly on the limited license state, working with operators who are vertically integrated, which has let us be selective about which borrowers we choose to support. Because of how disciplined we are, the portfolio we end up with offers higher yields and very strong collateral. Having said that, I'll pass things over to Tony, and Tony, please go ahead and take it from here.
Tony Cappell
executiveThanks, John. Good morning, everybody. We keep making progress on expanding what we have in the works, deploying money at returns and with collateral protection above the levels we aim for; we're also gaining traction with our platform thanks to solid connections, a focused lending push and a hard-won standing in the sector as the go-to financier for top cannabis businesses. Because our Q4 earnings call happened just 6 weeks back, I'd rather not go over a lot of what we covered and did at that time. What I'd like to focus on instead is what we got done in Q1 and so far in Q2 across the portfolio and with our originations group, plus drive home how we're delivering those outcomes. Let's begin with the how. Keep in mind that a few of our main points of distinction are having an in-house originations group that finds our loans and arranging those loans so that we serve as our borrower's sole debt provider, with the REIT acting as lead or co-lead on the facility. What ties both methods together is that we establish and nurture the connection with our borrowers. That connection matters greatly when it comes to expanding alongside them and also obtaining the monthly compliance reports and specifics that let us stay on top of operations and market conditions. I can't emphasize enough how vital it is to form relationships directly in the manner we do at Chicago Atlantic. We understand what our borrowers require, the timing of those needs and how they're navigating the difficulties of keeping up with faster demand for their product. In Q1, we funded $86.7 million in gross principal in total, coming from new and existing loan commitments. So far in Q2, we've funded another $25 million, with $17 million going to a new borrower and $8 million to an existing one. Year-to-date, we've seen 2 payoffs amounting to $3.6 million, bringing commitments to $337 million in total with a weighted average yield to maturity of 17.5% as of May 10. Finally, our pipeline feels boundless, with more than $900 million of near-term opportunities. As we look toward the rest of the year, we'll maintain a disciplined pace. It's obvious to us that operator demand for capital isn't running out, but we'll keep balancing that demand against the need to fund it through appealing capital sources, and we'll only select the very best deals. Last, I want to call attention to this quarter's dividend increase; for Q1, we distributed a dividend of $0.40 per share, which is a 54% rise over the Q4 dividend. That works out to an annualized rate of $1.60 per share, producing a yield of 9.73% based on the May 9 closing stock price and a 10.6% yield to book value. On top of that, we anticipate consistent dividend growth in the quarters ahead. At this point, Andreas is going to take us through what we're investing in, our capital plan, and how we did financially.
Andreas Bodmeier
executiveThank you, Tony. Morning, everyone. Since we covered our investing activity thoroughly in both the earnings release and the supplemental, I'll point to those two documents and then add a bit more color. As of March 31, our loan book had reached $321 million in total commitments spread over 22 portfolio companies. The weighted average yield to maturity stands at 17.2%; and, as Tony mentioned a moment ago, by May 10 the portfolio had climbed to $337 million, carrying a yield of 17.5%. Every loan remains current and performing. In the quarter, just a single loan, amounting to $3.1 million, was repaid when it came due. Worth noting: 63% of our portfolio right now is floating rate, tied to the prime rate. That has let us handle the effect of climbing rates so far. Demand for debt capital has never been stronger, and the deals we've brought into our pipeline keep hitting our yield targets. Right now, finding capital is both our biggest opportunity and our biggest hurdle. This quarter we drew on our IPO proceeds and, so far in Q2, have borrowed $30 million under the credit facility. We're working hard to expand that facility by bringing in more banks, so we can satisfy the rising demand reflected in our pipeline and signed term sheets. From the start, our aim has been to leverage this facility, and perhaps a bond or debt offering, to get to a target of just half a turn of leverage by the end of the year. If those routes can't deliver sufficient capital fast enough or on attractive terms, we'll turn to the equity markets during the second half of the year to support our growth. Now to our financial results for the first full quarter since becoming public. A few things stand out from our Q1 numbers. Our total interest income is starting to show the effect of putting IPO proceeds to work. Though interest income rose sequentially to $9.8 million from $5.8 million in Q4, we anticipate the complete impact of deploying IPO proceeds and drawing on the credit facility will show up in Q2. Total expenses came to $2 million for the quarter, including management and incentive fees of $671,000. Keep in mind those incentive fees were waived during Q4. G&A was $556,000, and professional fees were $557,000. We flagged on last quarter's earnings call that we planned to charge incentive fees for the first time in Q1. G&A lines up with the guidance we provided last quarter — $2.5 million to $3 million for the year — and the quarter-over-quarter rise in professional fees stemmed almost entirely from accounting and audit fees. Under ASC 326, we raised our provision for expected credit losses by $51,000 in Q1. In setting that reserve, we observed that 93% of the portfolio is fully secured by real estate, while 7% carries limited or no real estate collateral. As of March 31, '22, our portfolio's average real estate collateral coverage was 1.9x. Each of our loans has collateral behind it, consisting of borrower equity pledges plus liens on every asset. Although we restored the CECL reserve when figuring distributable earnings, just as we did in Q4, we made the choice not to restore incentive fees when calculating both distributable earnings and adjusted distributable earnings. That represents a modest change in definition compared with what we initially planned, yet we feel it's the correct call and gives a transparent picture of our capacity to make dividend payments to shareholders. Once those items are taken into account, adjusted distributable earnings per share came to $0.45 per diluted share in Q1. As we mentioned during the previous quarter, our weighted average share count in Q1 captures the bulk of the effect from the 17.8 million shares outstanding following the offering and the greenshoe exercise completed in January '22. Book value on March 31 stood at $15.17 per common share. Operator, we are ready to begin the question-and-answer session.
Aaron Hecht
analystClearly, you folks have been deploying money fast, and the returns look quite impressive. From what I gathered, you began drawing on the credit facility at some point in Q2. You laid out a few possibilities regarding capital, yet with the pipeline you've got, it appears availability could get pretty constrained before long. How soon do you think you'll be in a position to tap fresh capital on the debt side? What steps are you currently taking? Any kind of updates at all would help us figure out how to model out deployment.
Andreas Bodmeier
executiveWe do have room to grow our credit facility, we're upsizing it shortly, and there's also an indication of interest from additional banks in joining in; our attention is heavily on chasing debt during this quarter and the next one, which includes a debt offering. Of course, everyone knows that rates as well as spreads have gone up since the IPO took place. We'll only go ahead with a debt offering when it's accretive, and if not, we'll turn to the equity markets during the back half of the year.
Aaron Hecht
analystAnd on that point, clearly with rates having risen and valuations falling throughout cannabis, are you finding more chances among the bigger MSOs? Are they moving up your priority list in the pipeline? What's happened with the yield profile? Any kind of update you can give on borrower preference and your pipeline.
John Mazarakis
executiveAaron, John here. Lately, MSOs haven't really been our focus. The middle market is still where our main attention goes. Multistate operators working across 2 or 3 states definitely interest us, but our bread and butter is the middle market, and that's what we'll keep focusing on.
Mark Smith
analystCould you talk about how the split between first-time borrowers and returning ones looked over the quarter?
John Mazarakis
executiveAre you asking about Q1 specifically, or are you referring to year-to-date?
Mark Smith
analystNo. Regarding the first quarter — and honestly, if you'd prefer to provide the entire year-to-date figure, that works too, that would be excellent.
Tony Cappell
executiveSure. Most of those fundings went to new businesses. We upsized one that was already in the existing portfolio. And then, as we mentioned in the script, one of the fundings was an upsize. So 2 of them are upsizes, and the rest were new borrowers.
Mark Smith
analystAll right. And one of those increases came after Q1, is that right?
Tony Cappell
executiveYes, that's correct.
Mark Smith
analystGreat. Now I have 2 questions that are more broad in nature. Do you have any current perspective on shifting laws, fresh legalization efforts, specific states you're monitoring closely, or anything happening federally as you try to predict the future and perhaps expect or eagerly await?
John Mazarakis
executiveWe are looking forward to additional shifts from medical to recreational, much like what happened in New Jersey. For our industry, those usually create significant value. On the whole, we are not anticipating any form of consistent federal reform; that sums up our general stance of state versus federal.
Tony Cappell
executiveBuilding on that, what we've noticed is — clearly, regarding what John said about New Jersey, neighboring states tend to feel the impact; therefore, Pennsylvania is on our radar. Clearly, Delaware shows encouraging momentum, and then Maryland too, naturally. So those represent a few of the states we're monitoring that generate considerable opportunity in addition to fostering a far more solid climate for extending credit.
Mark Smith
analystAll right, and the final question from my side. I realize your attention has been on states with limited licensing, essentially. Are there any states worth mentioning that are experiencing a portion of this sector softness that's sort of spilling over from the West Coast? Any states worth mentioning that perhaps have — have experienced a shift in the nature of that softness?
Tony Cappell
executiveWell, to the east of the Mississippi, there are 2 states we're watching closely, and those are Michigan and Massachusetts. In those 2 states, there's been significant compression on both wholesale and retail pricing; so we're intently focused on comprehending those states at a granular level, and for now, we're deliberately keeping our distance from them.
John Mazarakis
executivePlus, these were items we understood from the start. From a state standpoint, they weren't restricted-license jurisdictions. So at least when it comes to wholesale, the emphasis has consistently remained on large-scale growers. And clearly, those operators will be the ones who make it through the difficult period and ultimately flourish, as things shift toward a more efficient market along the lines of Colorado; therefore we devote considerable effort to studying Colorado and the eventual curve of its price compression, and that is essentially the approach we took to that segment in those specific states.
Mark Smith
analystAll right, and can you remind us again — when we consider Michigan, which is one of those two, likely having a larger effect on the current portfolio, is that the correct way to think about it?
Tony Cappell
executiveThat's right.
Mark Smith
analystIs there anything worth highlighting regarding those loans when we consider CECL reserves — any cause for concern, or anything investors ought to keep an eye on in those states?
John Mazarakis
executiveNone whatsoever, Mark. In fact, our Michigan investment went to one of the biggest operators there, which likely has the state's lowest cost per pound. So from the start, in Michigan, we aimed at the spread instead of the pricier options. On top of that, Michigan is seeing consolidation, and that benefits some of the top operators in the sector. So it's fair to say we put money into one of Michigan's strongest companies.
Gaurav Mehta
analystLet's return to what you said regarding where the money comes from and how much more the credit line could give you. You've got $30 million drawn on it, and it tops out at $45 million. If you were to increase the size of it, what amount of capacity should we be thinking about? Then you mentioned a possible debt offering as well — if you went ahead and issued one, what rates do you expect?
John Mazarakis
executiveAs far as the credit facility goes, our expectation is that we'll upsize it step by step as additional banks come on board. There are several banks currently in the data room. This will occur gradually. And we expect to go past $100 million over the remainder of and midway through the year. On the debt side, we haven't approached the market yet. We know what the market looks like right now, with rates rising and spreads getting wider. Once this quarter is behind us, I believe we'll be putting a lot of emphasis on trying to pursue a debt offering; but to say it again, it must be accretive, and under no circumstances will we pursue a debt offering regardless of the cost.
Gaurav Mehta
analystAll right, that's helpful. My second question concerns your yields, which stood at 17.5% as of May. When you survey the market and consider the new loans, ought we to anticipate yields holding around the 17% to 18% mark? What's your expectation for how yields will move across the coming 12 to 18 months?
John Mazarakis
executiveSure; in fact, yield compression isn't something we're anticipating at all. My view is that rates are well placed to remain at their present levels.
John Mazarakis
executiveAlright, I appreciate all the analysts for those great questions, and we can't wait to take more questions down the road as our platform keeps expanding. Thanks to each of you for spending time with us today.
Operator
operatorAppreciate it, everyone. That wraps up our session for today. Thanks for joining in, and you're free to hang up at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chicago Atlantic Real Estate Finance, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Chicago Atlantic Real Estate Finance, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chicago Atlantic Real Estate Finance, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.